Clinical Trial Update: Olorofim Aspergillus Infection Study [Phase 3]

View source ↗

Summary

This clinical trial update indicates that olorofim is being studied in a Phase 3 trial for invasive aspergillosis, with the study currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Olorofim (olorofim)

Snippet

Sponsor: F2G Biotech GmbH | Conditions: Invasive Aspergillosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING